There is little time left for Athira Pharma Inc (ATHA) to reach its 1-year target estimate. How soon will it surpass it?

Athira Pharma Inc (NASDAQ:ATHA) shares traded 41.53% higher at $0.61 on Wall Street last session.

ATHA stock price is now -28.39% away from the 50-day moving average and -74.08% away from the 200-day moving average. The market capitalization of the company currently stands at $32.96M.

Top 5 Artificial Intelligence Stocks to Buy for 2024

By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it. According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

Sponsored

With the price target reduced from $5 to $0.50, Mizuho Downgraded its rating from Outperform to Neutral for Athira Pharma Inc (NASDAQ: ATHA). , while ‘JMP Securities’ rates the stock as ‘Mkt Perform’

In other news, Mark James Litton, Officer bought 5,032 shares of the company’s stock on Sep 05 ’24. The stock was bought for $1 at an average price of $0.00. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 05 ’24, CFO and Chief Business Officer Gengos Andrew sold 1,272 shares of the business’s stock. A total of $720 was realized by selling the stock at an average price of $0.57. This leaves the insider owning 97,532 shares of the company worth $59494.52. A total of 7.89% of the company’s stock is owned by insiders.

During the past 12 months, Athira Pharma Inc has had a low of $0.41 and a high of $4.30. As of last week, the company has a debt-to-equity ratio of 0.02, a current ratio of 3.97, and a quick ratio of 3.97. The fifty day moving average price for ATHA is $0.84622 and a two-hundred day moving average price translates $2.337305 for the stock.

The latest earnings results from Athira Pharma Inc (NASDAQ: ATHA) was released for 2024-06-30.

Related Posts